Related Experiment Videos

[Fungal infections in 100 patients subjected to heart transplantation]

D E Uip1, V Amato Neto, T M Varejão Strabelli

  • 1Divisão de Moléstias Infecciosas e Parasitárias e Instituto do Coração do Hospital das Clínicas-FMUSP, São Paulo.

Abstract

Insights

Fungal infections are a significant concern following heart transplantation, causing increased illness and three deaths in a recent study. Early diagnosis and treatment are crucial for managing these infections in transplant recipients.

Area of Science:

  • Medical Mycology
  • Transplant Infectious Diseases

Background:

  • Fungal infections pose a serious threat to immunocompromised patients, particularly those undergoing organ transplantation.
  • Understanding the epidemiology and clinical impact of fungal infections in heart transplant recipients is critical for patient outcomes.

Purpose of the Study:

  • To determine the prevalence, causes, clinical presentation, and mortality associated with fungal infections in heart transplant patients.
  • To analyze the specific fungal species and their impact on morbidity and mortality in this population.

Main Methods:

  • A prospective study of 100 consecutive heart transplant patients.
  • Diagnosis of fungal infections based on Centers for Disease Control criteria.
  • Follow-up duration ranged from 3 to 90 months (mean 25.38 months).

Main Results:

  • Forty-seven fungal infections were identified in the study cohort.
  • Candida albicans was the most frequent cause, leading to oral infections.
  • Other identified fungi included Acremonium sp., Aspergillus sp., Candida tropicalis, Histoplasma capsulatum, and Pneumocystis carinii.
  • Three deaths were directly attributed to fungal infections, highlighting their severity.

Conclusions:

  • Fungal infections contribute significantly to morbidity and mortality after heart transplantation.
  • Prophylactic and therapeutic strategies are recommended to mitigate the risks associated with these infections.
  • Further research into targeted antifungal interventions is warranted for heart transplant recipients.

Related Concept Videos